TRACON (TCON) implements 1-for-20 reverse stock split effective April 9, 2024

Tracon Pharmaceuticals, Inc.

Board approved 1-for-20 reverse stock split; effective 5:00 p.m. ET on April 9, 2024.
Post-split shares approx. 2.6 million; trading on split-adjusted basis from April 10, 2024.
No fractional shares; holders entitled to fractional share will receive one full post-split share.
Proportional adjustments to options, warrants, and equity plans; authorized shares unchanged at 60M.
New CUSIP 89237H308; symbol TCON continues on Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Tracon Pharmaceuticals, Inc.: Amended Certificate of Incorporation to effect a one-for-twenty reverse stock split (effective 2024-04-09).

Change: charter amendment
Effective: 2024-04-09

Exact text from the filing

On April 8, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment of its Amended and Restated Certificate of Incorporation (the “Charter Amendment”) to effect the one-for-twenty reverse stock split of the Company’s outstanding common stock.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0000950170-24-042440

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.